Fundraising Fox

Maven

New York, US Β· Founded 2014 Β· 1,183 employees on LinkedIn Β· 22 known investors

Maven delivers virtual healthcare and benefits management services for women and families through both an enterprise platform serving employers and health plans, and a direct-to-consumer platform offering access to 30+ specialties including hormone and GLP-1 care programs.

Also known as Maven Clinic

Founders & leadership

Maven was founded in 2014 by Kate Ryder.

KRKate Ryder
Kate Ryderin𝕏FounderFounder & CEO, Maven at xfactor ventures

Investors Β· 22

Also in the syndicate Β· 1

Sequoia

Company profile

researched Aug 2026

Maven, which operates as Maven Clinic, is a virtual healthcare company focused on women's and family health. Its programs are organized around life stages: Fertility & Family Building, Maternity & Newborn Care, Parenting & Pediatrics, and Menopause & Midlife Health. Members reach providers across more than 30 specialties β€” including OB-GYNs, nutritionists, doulas, lactation consultants and mental health specialists β€” with 24/7 access and support from Care Advocates. The platform combines care delivery with benefits administration, unifying clinical data, care history, wearable insights and benefit and coverage details in one system, and applies AI-driven personalization on top of a human-led care model.

The business has two channels. Maven Enterprise sells to employers, health plans and benefits consultants; Maven Managed Benefit is its fertility benefits administration product, which pairs a carve-out fertility benefit with virtual care and trying-to-conceive coaching and integrates a performance network of 475+ fertility clinics so members can see benefit and cost updates alongside their care. Maven Wallet handles benefits set-up and reimbursements, and Maven Milk covers breast-milk shipping. A separate self-pay consumer platform offers a virtual clinic across 30+ specialties plus dedicated hormone care (two visits with hormone health specialists, a personalized plan and prescription support) and GLP-1 care (brand-name GLP-1 prescriptions, visits with metabolic and hormone health specialists, and nutrition and strength support).

Maven also operates value-based maternity arrangements spanning commercial, fully-insured and Medicaid populations, and publishes research on its care model, including an open-access three-question social needs screener published in the American Journal of Obstetrics and Gynecology and studies on digital care to reduce C-section rates.

Founding story

Kate Ryder founded Maven in 2014 after witnessing and experiencing the lack of support available to people building and raising families, with the aim of creating a care model centered on women and families.

Business model

Maven sells subscription-style health benefits and care programs to employers, health plans and benefits consultants (Maven Enterprise), including fertility benefits administration through Maven Managed Benefit, where programs are free to members because they are covered by the employer or health plan. It also offers value-based arrangements with employers and health plans, and runs a self-pay direct-to-consumer service for virtual clinic visits, hormone care and GLP-1 care.

Employer and health plan contracts for care programs and benefits administration, value-based partnerships in maternity care across commercial, fully-insured and Medicaid lines of business, and self-pay consumer purchases of virtual clinic, hormone and GLP-1 programs.

Traction

Company materials report more than 2,300 employer and health plan clients, 15 million lives under management (with the site citing a network supporting 28 million lives), service in 175+ countries, and 40+ peer-reviewed studies. As of the October 2024 Series F announcement: 2,000+ clients, 15 published peer-reviewed studies, 400%+ year-over-year client growth in Maternity & Newborn Care, a doubling of Parenting & Pediatrics membership over 12 months to more than 3 million lives under management, 300% year-over-year growth in Menopause & Midlife with 550+ clients offering it, and a tripling of Medicaid market presence since 2022. Reported outcomes include up to 27% lower NICU admissions, C-section reductions of 8-20%, NICU admission reductions of 20-28%, 2:1 clinical ROI, and up to $9,600 in savings per member.

Latest developments

Maven has introduced self-pay consumer products β€” a virtual clinic covering 30+ women's and family health specialties, a hormone care program, and a GLP-1 care program including brand-name prescriptions and metabolic and hormone specialist visits. Following its Series F, stated priorities include expanding Maven Managed Benefit, applying AI to personalize care and automate administrative and payments functions, deepening support for high-risk maternity members, broadening Menopause & Midlife into healthy aging and chronic conditions, and growing value-based offerings across fully-insured and Medicaid populations.

β–ΈFull profile β€” market position, technology, go-to-market, geography, history, risks & controversies

Market position

The company describes itself as the world's largest virtual clinic for women's and family health and, as of October 2024, the largest fertility benefits provider globally by lives under management. It reports the largest virtual care network in its category, supporting 28 million lives worldwide, and offers a global benefit covering the reproductive life cycle from preconception through menopause on one platform.

Coverage of the full reproductive life cycle on a single platform rather than point solutions; integration of care delivery with benefits coverage and cost transparency (notably Maven Managed Benefit, which combines fertility care, coaching and coverage administration); a provider network spanning 30+ specialties and 30 provider languages with global reach; and an evidence base of peer-reviewed studies and Milliman-validated, claims-based outcome studies.

Technology

A single platform that unifies clinical data, care history, wearable insights and benefit information, described by the company as AI-native. It applies AI-driven personalization across millions of data points, automates administrative functions in its payments product, and supports providers and care coaches with tooling; members book on-demand virtual appointments without referrals. Company materials cite predictive insights and integration of its fertility clinic network into the virtual experience.

Go-to-market

Enterprise sales to employers, health plans and benefits consultants supported by demo requests, claims-based outcome studies and peer-reviewed research aimed at HR and benefits leaders, plus webinars and benefits-industry content. A parallel direct-to-consumer motion sells virtual clinic, hormone and GLP-1 programs on a self-pay basis, and a provider recruitment channel enrolls clinicians into the care network.

Employers, health plans and benefits consultants purchasing women's and family health benefits, including large enterprises such as Amazon, Microsoft, AT&T, Morgan Stanley, L'Oreal, SoFi and Vynamic; Medicaid and fully-insured populations via health plan partners; and individual consumers paying directly for virtual care.

Geography

Headquartered in New York, with care, coverage and reimbursement across 175+ countries and localized support delivered in 30 provider languages.

History

Founded in 2014, Maven launched its Maternity & Newborn Care program in its first year and added a Parenting & Pediatrics product in 2020 to support parents during the COVID-19 pandemic. It began expanding into Medicaid and value-based maternity care, tripling its Medicaid presence since 2022, and by 2024 had built out fertility, maternity, parenting and pediatrics, and menopause and midlife programs plus the Maven Managed Benefit fertility benefits administration platform. In October 2024 it raised a $125 million Series F, bringing total funding to more than $425 million, and has since added self-pay consumer offerings including a virtual clinic and hormone and GLP-1 care programs.

Risks & controversies

Company materials note that individuals face continuing barriers to care, including limited provider access, rising costs, systemic inequities, and legal and regulatory limitations.

Compiled by commissioned research from 8 cited public sources β€” announcements, filings, and press listed under research sources below.

Key figures

latest reported
Claims-based studiesJan 20256 studies
ClientsOct 20242,000 clients
Clients offering Menopause & Midlife programOct 2024550 clients
Clinical ROI for employers and health plansOct 20242:1
Countries servedJan 2025175
Employer and health plan clientsJan 20252,300 clients
Fertility clinics in performance networkOct 2024475 clinics
Fertility members achieving pregnancy without Assisted Reproductive TechnologyJan 202530%
Fertility members more likely to conceive without treatment with coachingJan 202555%
HeadcountAug 20261,183
Lives supported by virtual care networkJan 202528,000,000 lives
Lives under managementJan 202515,000,000 lives
Maternity & Newborn Care year-over-year client growthOct 2024more than 400%
Members reporting improved maternal mental healthJan 2025Up to 21%
Members reporting Maven helped them return to work after having a babyJan 2025Up to 40%
Menopause & Midlife year-over-year growthOct 2024300%

Company-reported or press-reported figures, each dated to when it was claimed β€” not independently audited.

Competitors Β· 1

by search overlap

Companies competing with Maven for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline Β· 10

launches, deals, and filings
Jan 2025
Self-pay consumer offerings: Virtual Clinic, Hormone Care and GLP-1 Care

Maven introduced self-pay consumer products, including a virtual clinic spanning 30+ women's and family health specialties, a hormone care program with two specialist visits, a personalized care plan and prescription support, and a GLP-1 care program with brand-name prescriptions, metabolic and hormone specialist visits, and nutrition and strength support.

source β†—

Oct 2024
Maven Clinic announces $125 million Series F

Maven Clinic announced a $125 million Series F round led by StepStone Group with participation from General Catalyst, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group and Lux Capital, bringing total funding to more than $425 million. Proceeds were earmarked for Maven Managed Benefit, the end-to-end care platform, AI investment, and value-based offerings across fully-insured and Medicaid populations.

$125M source β†—

Jan 2023
CNBC Disruptor 50

source β†—

Jan 2023
Fast Company Most Innovative Companies

source β†—

Jan 2023
TIME 100 Most Influential Companies

source β†—

Jan 2022
CB Insights Digital Health 150

source β†—

Jan 2022
Fortune Best Workplaces for Women and Best Workplaces in Health Care

source β†—

Jan 2022
Inc. Best in Business

source β†—

Jan 2021
Rock Health Disruptive Founder of the Year

source β†—

Jan 2020
Parenting & Pediatrics program launched

Maven first launched its Parenting & Pediatrics product in 2020 to support parents during the COVID-19 pandemic; it was later expanded to cover specialty pediatric care and complex learning and behavioral challenges.

source β†—

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

β–ΈResearch sources Β· 8

primary sources listed
  • Mavenmavenclinic.com Β· web

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Maven do?
Virtual clinic for women's and family health, sold to employers and health plans and directly to consumers.
Who founded Maven?
Maven was founded by Kate Ryder in 2014.
Who are Maven's investors?
Maven's investors include 125 Ventures, Able Partners, AlleyCorp, City Light, Colle Capital Partners, CVS Health Ventures, Female Founders, Flucas Ventures and 13 more.
Where is Maven headquartered?
Maven is headquartered in New York, US.